- Home


June 27, 2018
Frankfurt, Germany

:  - Innovation 2018 CSI Focus Innovation 2018

Innovation 2018
27 June, 2018
Frankfurt, Germany



Please keep me
updated
csi pfeil
subscribe now

Innovation 2018 Board of Directors Faculty Scientific Program Registration Topics Key Information Event Calendar Sponsors Archive
Fontsize bigger
  :
:

Board of Directors

Horst Sievert, MD

CardioVascular Center Frankfurt CVC
Frankfurt
Germany

Board of Directors: Horst Sievert, MD
More

Horst Sievert, MD

CardioVascular Center Frankfurt CVC
Frankfurt, Germany

Board of Directors: Horst Sievert, MD
Director and Founder of CVC Frankfurt

Specialist in Internal Medicine, Cardiology, Angiology, and Intensive Care

Medical degree from Johannes Gutenberg University Mainz and Johann Wolfgang Goethe University Frankfurt, Germany

Dr. Sievert has been the Principal Investigator of a number of clinical trials and has authored more than 130 manuscripts and 600 abstracts in peer reviewed journals, as well as 70 books and book contributions. He has also delivered more than 600 invited lectures around the world.
 
He has personally performed more than 16,000 PCIs and 6,000 peripheral angioplasties. However, his activity in the cath lab is focused on highly specialized non-coronary interventions for patients with congenital heart disease, carotid disease, or high risk of stroke, among other conditions. Dr Sievert was the first to close the left atrial appendage percutaneously. He has the largest experience worldwide in catheter closure of heart defects in adults and gets referrals from all over the world.

Sameer Gafoor, MD

Swedish Heart and Vascular Institute
Seattle
USA

Board of Directors: Sameer  Gafoor, MD
More

Sameer Gafoor, MD

Swedish Heart and Vascular Institute
Seattle, USA

Board of Directors: Sameer  Gafoor, MD
Attending Physician

Dr. Sameer Gafoor is an attending physician at the CardioVascular Center (CVC) Frankfurt headed by Horst Sievert, MD. He obtained his medical degree from Northwestern University in the United States, followed by Internal Medicine Residency at University of michigan. His cardiology training started with Cardiovascular Disease Fellowship at Washington Hospital Center/Georgetown University and continued with Interventional Cardiology Fellowship at Emory University.

Following this training, he went on to complete an Advanced Fellowship in Neurovascular, Coronary, Structural Heart, and Peripheral Vascular Training at the CVC Frankfurt. He specializes in interventions and imaging for structural heart and peripheral vascular disease, as well as development and incorporation of new devices, technologies, and techniques for these and other indications.

Todd Brinton, MD

Stanford University
Stanford
USA

Board of Directors: Todd Brinton, MD
More

Todd Brinton, MD

Stanford University
Stanford, USA

Board of Directors: Todd Brinton, MD
Todd Brinton is a Clinical Associate Professor of Medicine (Cardiology) and Consulting Associate Professor of Bioengineering at Stanford University. He is an attending interventional cardiologist at both Stanford University Medical Center and the Palo Alto VA Medical Center. He has served as the Innovation Fellowship Director for Stanford Biodesign since 2005 and also co-directs the Stanford graduate course series in Biodesign Innovation.

Dr. Brinton lectures on strategies for innovation and serves as a mentor to innovation fellows, graduate students, and executives. His academic research focuses on the process of innovation for development of novel medical technologies. He specifically focuses on the integration of research and development for new technologies with the clinical strategy and pre-clinical evaluation. He has served as a clinical investigator for a number to studies of interventional-based therapies for chronic ischemia heart disease and heart failure.

Dr. Brinton completed his medicine, cardiology, and interventional cardiology training at Stanford University. He holds an MD from the Chicago Medical School and a BS in Bioengineering from the University of California, San Diego. He is Co-Founder and Board Director for Shockwave Medical and BioParadox, Inc., which are both venture-backed medical device companies in the cardiovascular space. He also serves on the board of directors of Qool Therapeutics and Infogard Laboratories. In addition, he serves on the advisory board of a number of early-stage medical device companies, where he focuses on clinical development and strategy. Prior to medical school, he was the Clinical Research Director for Pulse Metric, Inc., a venture-backed medical device start-up company.
CSI   CSI
Contact Data Privacy Imprint Home CSI 2017